Investment Analysis News 21 December 2025

Texas Instruments Stock (NASDAQ: TXN) Week Ahead Outlook: New Sherman Fab Starts Production as Wall Street Splits on 2026 Recovery

December 21, 2025 — Texas Instruments Incorporated (NASDAQ: TXN) heads into the Christmas-shortened trading week with investors balancing two powerful, and competing, narratives: a long-term U.S. manufacturing expansion that just hit an operational milestone, and a near-term debate about margins,

21 December 2025

Company News·Investment Analysis·Semiconductor Industry·Stock Market

Rocket Lab Stock (RKLB) Week Ahead: Record Close After $816M Space Force Satellite Deal—Catalysts, Forecasts, and Key Risks to Watch

As of Sunday, December 21, 2025, Rocket Lab Corporation stock (NASDAQ: RKLB) is heading into a holiday-shortened trading week after a stunning two-day surge that pushed shares to a record close of $70.52 on Friday, December 19. The rally has

21 December 2025

Defense Contracts·Financial Forecasts·Investment Analysis·Space Industry·Stock Market

ServiceNow (NOW) Stock Week Ahead: Armis Deal Chatter, Moveworks Integration, 5-for-1 Split Fallout, and Fresh Analyst Targets

ServiceNow, Inc. (NYSE: NOW) heads into the week of December 22–26, 2025 with momentum in its product narrative—but also with headline risk that has recently dominated the stock. The company has closed its largest acquisition to date (Moveworks), announced a

21 December 2025

Analyst Ratings·Investment Analysis·Mergers and Acquisitions·Stock Market·Technology Stocks

AbbVie Stock Week Ahead (Dec. 22–26, 2025): ABBV Holds Near $227 as Drug-Pricing Headlines Collide With Fresh Analyst Upgrades

As of Sunday, December 21, 2025, AbbVie Inc. (NYSE: ABBV) heads into a holiday-shortened trading week with shares hovering near the mid-$220s, after a high-volume rebound into Friday’s close. The setup for the week ahead is defined by two competing

21 December 2025

Drug Pricing·Financial News·Investment Analysis·Pharmaceuticals·Stock Market

Amgen (AMGN) Stock Week Ahead Forecast: Drug-Price Deal Fallout, Analyst Targets, and Year-End Catalysts to Watch (Dec. 22–26, 2025)

Amgen Inc. (NASDAQ: AMGN) heads into the Christmas-shortened trading week with a fresh wave of policy headlines, a newly expanded FDA label win in rare disease, and a market still laser-focused on what comes next for its obesity pipeline. Shares

21 December 2025

Financial Forecasts·Investment Analysis·Market Trends·Pharmaceutical Industry·Stock Market

Exxon Mobil Stock (XOM) Week Ahead Outlook: Oil Prices, Analyst Targets, and Key Catalysts for Dec 22–26, 2025

As of Sunday, December 21, 2025, Exxon Mobil Corporation (NYSE: XOM) is heading into a holiday-shortened trading week with two big forces likely to drive near-term price action: oil-market volatility and fresh investor digestion of Exxon’s upgraded 2030 plan. XOM

21 December 2025

Energy Sector·Financial Forecasts·Investment Analysis·Oil Industry·Stock Market

Salesforce (CRM) Stock Week Ahead: Qualified Acquisition, Agentforce Meets ChatGPT, and Analyst Price Targets to Watch (Dec. 22–26, 2025)

Salesforce, Inc. (NYSE: CRM) heads into the Christmas holiday week with a busy backdrop for investors: fresh product distribution news for its Agentforce platform, a newly announced acquisition aimed at “agentic” marketing, and a market calendar that’s likely to amplify

21 December 2025

Investment Analysis·Mergers & Acquisitions·Salesforce News·Stock Market

Ondas Holdings (ONDS) Stock News on Dec. 21, 2025: December Deals, Defense Expansion, and Analyst Forecasts for 2026

Dec. 21, 2025 — Ondas Holdings Inc. (NASDAQ: ONDS) has become one of the market’s more polarizing small-cap defense-tech stories: part autonomous drones, part counter-drone (“counter-UAS”), part ground robotics, and—often forgotten in the headlines—part private industrial wireless networking. December brought

21 December 2025

Company Updates·Defense Industry·Financial Forecasts·Investment Analysis·Stock Market News

Nike Stock (NKE) Week-Ahead Outlook: Tariffs, China, and Post-Earnings Volatility in Focus (Dec. 22–26, 2025)

As of Dec. 21, 2025, Nike, Inc. (NYSE: NKE) enters a holiday-shortened week with investors still digesting a sharp post-earnings selloff—and with a familiar question back at center stage: is the turnaround gaining traction, or simply getting more expensive? Reuters

21 December 2025

Earnings Reports·Investment Analysis·Nike·Stock Market

Lam Research Stock Week Ahead (LRCX): Analysts Lift Targets as AI Chip Spending Outlook Brightens Into a Holiday-Shortened Market

Week ahead: Dec. 22–26, 2025 (report written Dec. 21, 2025) Lam Research Corporation (NASDAQ: LRCX) is heading into the Christmas week on a surge of optimism that has pushed the semiconductor equipment maker to fresh highs—powered by bullish analyst notes,

21 December 2025

AI Technology·Investment Analysis·Market Outlook·Semiconductors·Stock Market

Cisco Stock (CSCO) Week-Ahead Outlook: AI Networking Tailwinds Meet a New Zero‑Day Risk (Dec 22–26, 2025)

Cisco Systems, Inc. (NASDAQ: CSCO) enters the Christmas-shortened trading week with momentum: shares last traded around $78.42 (latest available close from Friday, Dec. 19, 2025) and sit within reach of a $80.82 52‑week high. Simply Wall St But the coming

21 December 2025

AI Trends·Investment Analysis·Stock Market·Technology

Netflix (NFLX) Stock Week Ahead: Warner Bros Deal Headlines, Analyst Targets, and Key Levels to Watch (Dec. 22–26, 2025)

As the market heads into a holiday-shortened trading week, Netflix, Inc. (NASDAQ: NFLX) is entering a critical stretch where headline risk—not earnings—may be the biggest near-term catalyst. Investors are trying to balance three big forces: (1) deal-driven volatility tied to

21 December 2025

Financial News·Investment Analysis·Netflix·Stock Market